Navigation Links


IIB at Biology News

IIB at Biology Products

Mouse Anti-Verotoxin IIbeta Monoclonal Antibody, Unconjugated, Clone 457 from Santa Cruz Biotechnology, Inc.

Description:Verotoxin IIbeta (457)...
Company:Santa Cruz Biotechnology, Inc.

Rabbit Anti-Human Protein Kinase-A (PKA) Regulatory subunit IIB Antibody, Unconjugated from CEDARLANE Laboratories Limited

Description:Anti-Protein Kinase-A (PKA) Regulatory subunit IIB; rabbit host...
Company:CEDARLANE Laboratories Limited

Goat Anti-Human TGF-beta RIIb Polyclonal Antibody, Unconjugated from R&D Systems

Description:Human TGF-beta RIIb Affinity Purified Polyclonal Ab...
Company:R&D Systems
IIB at Biology Technology
IIB at Medicine News
IIB at Medicine Products

VerifyNow IIb/IIIa Assay

Description:The VerifyNow IIb/IIIa Assay is an automated, turbidimetric, whole- blood assay designed to assess platelet function based upon the ability of activated platelets to bind to fibrinogen coated beads. The detection well of the VerifyNow IIb/IIIa assay device contains all of the necessary reagents to perform this analysis. Within the well is an activator that induces the platelet to change the confo...
Company:Accumetrics
IIB at Medicine Technology

YM BioSciences Announces Secondary Efficacy and Safety Findings in Randomized Phase IIB Aerolef Trial

- Company Announces Lead Investigator for U.S. Trial - MISSISSAUGA, ON, July 11, 2007 /PRNewswire-FirstCall/ - YMBioSciences Inc. , an oncology company that identifies, developsand commercializes differentiated products for patients worldwide,today announced results of secondary endpoint data from its 99patient, randomized, placebo-controlled, multi-center Phase IIbtrial (DLXLEF-AP4) with...

Phase IIIb Clinical Data Validate the Overall and Cardiovascular Safety Profile of Cycloset (A Quick Release Formulation of Bromocriptine Mesylate) in Patients with Type 2 Diabetes

Data Also Support Drug's Efficacy at Improving Glycemic Control andReducing Diabetic Cardiovascular Complications CHICAGO, Ill., June 23, 2007 /PRNewswire/ -- VeroScience, LLC,in conjunction with its commercialization partner S2 Therapeutics,Inc., reported today the results of its Phase IIIb clinical trialsupporting the overall and cardiovascular safety of Cycloset(TM) (Aquick release for...

Antisense Pharma: Promising Phase IIb Results of Targeted Therapy with AP 12009 in Recurrent Anaplastic Astrocytoma

CHICAGO and REGENSBURG - June 21, 2007 - “In anaplasticastrocytoma, AP 12009 as a monotherapy is actually clearly superiorto temozolomide,” Prof. Albert Wong, M.D., StanfordUniversity, California, U.S.A. commented on the international PhaseIIb study with the TGF-beta 2-inhibitor AP 12009, under developmentby Antisense Pharma. Prof. Wong discussed the results of the studyin th...

ISTA Pharmaceuticals Announces Positive Preliminary Results from Ecabet Sodium Phase IIb Study

- Pending Final Analysis of the Results, ISTA Plans to InitiatePhase III Studies in Dry Eye in 2008 - IRVINE, Calif., May 31, 2007 /PRNewswire-FirstCall/ -- ISTAPharmaceuticals, Inc. , today announced positive results from thepreliminary analysis of the Company's Phase IIb clinical study ofecabet sodium, which is being developed as a treatment for dry eyesyndrome. Patients in the ecabet s...

Alexza Pharmaceuticals to Present AZ-001 Phase IIb Clinical Data at the American Headache Society Meeting

PALO ALTO, Calif., May 31, 2007 /PRNewswire-FirstCall/ -- AlexzaPharmaceuticals, Inc. announced today that it will present at the49th Annual American Headache Society Meeting the results of aPhase IIb clinical trial of Staccato(R) prochlorperazine (AZ-001)for the acute treatment of migraine headache. The posterpresentation, "Efficacy and tolerability profile of AZ-001(Staccato prochlorpe...

More>>

Other TagsAngledAngledSutureTennantJaffeTyingSheets
(Date:8/29/2008)...esults of a 10-year study published in the August ...found that magnesium sulfate administered to women...he risk of cerebral palsy by 50 percent. The Benef...) trial was conducted in 18 centers in the U.S., i...renatal intervention ever found to reduce the inst...
(Date:8/29/2008)... http://www.aronowitzmd.com [Los An...espected experience in plastic surgery procedures ...consideration may be necessary for these patients,...e an established specialty of procedures for after...es, CA (PRWEB) August 29, 2008 -- Bariatric surger...
(Date:8/28/2008)...ues increase 138% versus Q2 2007 - Nine new Cen...RNewswire-FirstCall/ - CRH Medical Corporation,(CR... three and six months,ended June 30, 2008 (all fig...ths ended June 30, 2008 increased 138% to $1,653,8...7. Revenue for the six months ended June,30, 2008 ...
(Date:8/28/2008)...ion will be based in the Northeast region with mor...xt year, HARRISBURG, Pa., Aug. 28 /PRNewswire-USN...ity has hired a Patient Safety Liaison for the,Nor...eport to the,Pennsylvania Patient Safety Reporting...ylvania citizens., "Last year in focus groups wit...
Breaking Medicine News(10 mins):Health News:National study shows magensium sulfate reduces risk of cerebral palsy in premature births 2Health News:Dr. Joel Aronowitz, Specialist in Los Angeles Body Lift, Announces Plastic Surgery Options After Bariatric Surgery Weight Loss 2Health News:Dr. Joel Aronowitz, Specialist in Los Angeles Body Lift, Announces Plastic Surgery Options After Bariatric Surgery Weight Loss 3Health News:Dr. Joel Aronowitz, Specialist in Los Angeles Body Lift, Announces Plastic Surgery Options After Bariatric Surgery Weight Loss 4Health News:CRH Medical reports Q2 2008 results 2Health News:CRH Medical reports Q2 2008 results 3Health News:CRH Medical reports Q2 2008 results 4Health News:CRH Medical reports Q2 2008 results 5Health News:Pennsylvania Patient Safety Authority Hires Patient Safety Liaison to Help Healthcare Facilities Implement Guidance 2Health News:Pennsylvania Patient Safety Authority Hires Patient Safety Liaison to Help Healthcare Facilities Implement Guidance 3
(Date:8/28/2008)... NEW YORK (AUGUST 28, 2008) A WCS repor...obally threatened primates in a protected area in ...anked douc langurs along with 2,500 yellow-cheeked...Conservation Area, an estimate that represents the... world., , WCS scientists conducted the surveys...
(Date:8/28/2008)...archers at The University of Nottingham have devel...s to look at microscopic activity within the body,...e, live as it happens. , The cutting edge laser ...the MRC (Medical Research Council) for a five-year...ny world of activity taking place within single ce...
(Date:8/28/2008)... Journal of Nutrition, Health and Aging publishes...nteraction between nutrition and health in the agi... latest scientific findings on the fundamental imp...span. The journal is published ten times a year in..., "The partnership with Springer from 2009 shoul...
(Date:8/27/2008)...ting in Nature Genetics, and working in conjunct...stered fund that is dedicated to exploring new ave...ty, scientist Robert Hoffmann, has developed the f...n a powerful authorship tracking technology, this ...sponding author. In this way readers can always kn...
Breaking Biology News(10 mins):Unexpected large monkey population discovered 2Life under the laser 2ETH Zurich-administered fund ends scientific anonymity 2Elekta Announces First Volumetric Modulated Arc Therapy Cancer Treatment at Royal Marsden Hospital 3176 1Elekta Announces First Volumetric Modulated Arc Therapy Cancer Treatment at Royal Marsden Hospital 3176 2Arobella Medical LLC Launches Qoustic Wound Therapy System 28TM 29 3174 1Arobella Medical LLC Launches Qoustic Wound Therapy System 28TM 29 3174 2Arobella Medical LLC Launches Qoustic Wound Therapy System 28TM 29 3174 3AtriCure Announces Initiation of the ABLATE Pivotal Trial to Evaluate the Isolator Synergy 28TM 29 Bipolar Ablation System to Treat Atrial Fibrillatio 3172 1AtriCure Announces Initiation of the ABLATE Pivotal Trial to Evaluate the Isolator Synergy 28TM 29 Bipolar Ablation System to Treat Atrial Fibrillatio 3172 2AtriCure Announces Initiation of the ABLATE Pivotal Trial to Evaluate the Isolator Synergy 28TM 29 Bipolar Ablation System to Treat Atrial Fibrillatio 3172 3AtriCure Announces Initiation of the ABLATE Pivotal Trial to Evaluate the Isolator Synergy 28TM 29 Bipolar Ablation System to Treat Atrial Fibrillatio 3172 4American Chemical Societys Weekly PressPac Feb 6 2008 11486 1American Chemical Societys Weekly PressPac Feb 6 2008 11486 2American Chemical Societys Weekly PressPac Feb 6 2008 11486 3American Chemical Societys Weekly PressPac Feb 6 2008 11486 4American Chemical Societys Weekly PressPac Feb 6 2008 11486 5American Chemical Societys Weekly PressPac Feb 6 2008 11486 6American Chemical Societys Weekly PressPac Feb 6 2008 11486 7American Chemical Societys Weekly PressPac Feb 6 2008 11486 8American Chemical Societys Weekly PressPac Feb 6 2008 11486 9
Other Contentshormonehormonehormonehormonehormonehormonehormonehormonehormoneprojectprojectprojectprojectprojectprojectprojectprojectprojectgenomegenomegenomegenomegenomegenomegenomegenomehumanhumanhumanhumanhumanhumanhumanhumanhumanhumanhydrolysishydrolysishydrolysishydrolysishydrolysishydrolytic